1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
The cannabinoid receptor 2 (CB2 receptor) has attracted considerable interest, mainly due to its potential as a target for therapeutics for treating various diseases that have a neuroinflammatory or neurodegenerative component while avoiding the adverse psychotropic effects that accompany CB1 recept...
Guardado en:
Autores principales: | Amer H. Tarawneh, Pankaj Pandey, Lo'ay A. Al-Momani, Anastassiya V. Gadetskaya, Sultan T. Abu-Orabi, Robert J. Doerksen, Stephen J. Cutler |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e155f8c981fa43f99cbbbced5bbfc653 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploring the Ligand Efficacy of Cannabinoid Receptor 1 (CB1) using Molecular Dynamics Simulations
por: Sang Won Jung, et al.
Publicado: (2018) -
Astroglial CB1 Cannabinoid Receptors Mediate CP 55,940-Induced Conditioned Place Aversion Through Cyclooxygenase-2 Signaling in Mice
por: Jin Cong, et al.
Publicado: (2021) -
Localization of Cannabinoid Receptor 1 (CB1) in Submandibular and Sublingual Salivary Glands of Mice throughout Postnatal Development
por: Hipkaeo,Wiphawi, et al.
Publicado: (2015) -
The Vertical and Horizontal Pathways in the Monkey Retina Are Modulated by Typical and Atypical Cannabinoid Receptors
por: Joseph Bouskila, et al.
Publicado: (2021) -
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
por: Francisco Navarrete, et al.
Publicado: (2021)